ON-TARGET Study: Improving Supportive Care for Advanced Cancer

This study, called ON-TARGET, is looking at how to provide better supportive care for people with advanced cancer. It's testing if timely referral to palliative care (specialized medical care for people with serious illnesses) and enhanced usual care can improve how often people have an outpatient palliative care consultation. You might be able to join if you are at least 18 years old, have been recently diagnosed with metastatic solid tumors (cancer that has spread), and can speak English or Spanish. The study will measure success by looking at how many participants have an outpatient palliative care consultation at 12 and 24 weeks after screening. The current recruitment status is unclear.

Study design
This study plans to enroll 300 participants. It is an interventional study, meaning participants will receive specific interventions.
What's involved
You will complete questionnaires and physical exams. The primary endpoint is measured through study completion, which is an average of 1 year.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, a self-report questionnaire, will be measured through study completion, an average of 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07674797

Oncologic Timely Palliative Care And Remote Monitoring With Electronic Assessments And Telehealth (ON-TARGET)

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
M.D. Anderson Cancer Center
~300 participants
Updated 2026-06-30 on ClinicalTrials.gov
What's tested:Questionnaire and Physical Exam

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Self Report Questionnaire
Measured over Through study completion; an average of 1 year
Oncologic
Palliative Care
Remote Monitoring
Electronic Assessments
Telehealth

NCT07674797

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • MD Anderson Cancer Center

    Houston, Texasstudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • David Hui, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

  • Self Report QuestionnaireThrough study completion; an average of 1 year